Firstly, we discussed the epidemiology and various risk factors such as genetic mutations ( BRCA1/2, TP53, PTEN ), hormonal influences, several lifestyle risk factors (obesity, smoking, etc.), and environmental factors (chemical exposure, air pollutants, etc.)
A programme of phase 3 trials with retatrutide (TRIUMPH) is ongoing with an aim to assess the safety and efficacy of retatrutide in different populations living with obesity (OSA, T2D, established cardiovascular disease, osteoarthritis)
Defense Against Liver Diseases Research suggests that glutathione may act as a safeguard against various liver diseases, including non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease, and viral hepatitis
Formulation modification Liposomes are widely recognized as effective drug delivery platforms for enhancing pharmacokinetic characteristics, and their multiple surface modifications facilitate tissue-specific targeting [113]
T., Gault, J